1. Home
  2. TEX vs PRAX Comparison

TEX vs PRAX Comparison

Compare TEX & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Terex Corporation

TEX

Terex Corporation

HOLD

Current Price

$52.83

Market Cap

7.7B

Sector

Industrials

ML Signal

HOLD

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$268.16

Market Cap

8.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TEX
PRAX
Founded
1933
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.7B
8.3B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
TEX
PRAX
Price
$52.83
$268.16
Analyst Decision
Buy
Strong Buy
Analyst Count
14
21
Target Price
$76.09
★ $650.00
AVG Volume (30 Days)
★ 1.4M
490.3K
Earning Date
10-28-2026
11-04-2026
Dividend Yield
★ 1.34%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.20
N/A
Revenue
★ $5,421,000,000.00
N/A
Revenue This Year
$50.31
N/A
Revenue Next Year
$7.48
$39,256.17
P/E Ratio
$253.50
★ N/A
Revenue Growth
★ 5.73
N/A
52 Week Low
$41.70
$154.46
52 Week High
$74.69
$392.70

Technical Indicators

Market Signals
Indicator
TEX
PRAX
Relative Strength Index (RSI) 34.89 38.80
Support Level $50.64 $238.77
Resistance Level $62.24 $356.02
Average True Range (ATR) 2.07 12.63
MACD -0.07 -0.52
Stochastic Oscillator 7.66 35.55

Price Performance

Historical Comparison
TEX
PRAX

About TEX Terex Corporation

Terex is a global manufacturer of aerial work platforms, materials processing equipment, and specialty equipment for the waste, recycling, and utility industries. Its current composition is a result of numerous acquisitions over several decades to focus on a smaller group of light construction and other vocational equipment, having divested a handful of underperforming businesses, particularly in cranes and other lifting equipment. These remaining segments see heavy demand in nonresidential construction (aerial work platforms—40% sales), aggregates/mining (materials processing—30% sales), environmental, waste/recycling and utilities (environmental solutions group—30% sales).

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

Share on Social Networks: